◀ Back to TP53
CARM1 — TP53
Pathways - manually collected, often from reviews:
-
NCI Pathway Database Direct p53 effectors:
GCN5-L/ADA2B/TAF9 complex (KAT2A-TADA2B-TAF9)
→
p53/Cbp/p300/CARM1/PRMT1 (tetramer) complex (TP53-EP300_CREBBP-CARM1-PRMT1)
(transcription, activates)
An et al., Cell 2004, Gamper et al., Mol Cell Biol 2008
Evidence: mutant phenotype, reporter gene, physical interaction
-
NCI Pathway Database Direct p53 effectors:
PRMT1 (PRMT1)
→
p53/Cbp/p300/CARM1/PRMT1 (tetramer) complex (TP53-EP300_CREBBP-CARM1-PRMT1)
(modification, collaborate)
An et al., Cell 2004
Evidence: mutant phenotype, physical interaction
-
NCI Pathway Database Direct p53 effectors:
p53/Cbp/p300/CARM1/PRMT1 (tetramer) complex (TP53-EP300_CREBBP-CARM1-PRMT1)
→
nucleus (EP300/CREBBP)
(modification, collaborate)
An et al., Cell 2004
Evidence: mutant phenotype, physical interaction
-
NCI Pathway Database Direct p53 effectors:
p53/Cbp/p300/CARM1/PRMT1 (tetramer) complex (TP53-EP300_CREBBP-CARM1-PRMT1)
→
CARM1 (CARM1)
(modification, collaborate)
An et al., Cell 2004
Evidence: mutant phenotype, physical interaction
-
NCI Pathway Database Direct p53 effectors:
p53/Cbp/p300/CARM1/PRMT1 (tetramer) complex (TP53-EP300_CREBBP-CARM1-PRMT1)
→
p53 (tetramer) complex (TP53)
(modification, collaborate)
An et al., Cell 2004
Evidence: mutant phenotype, physical interaction
-
NCI Pathway Database Direct p53 effectors:
CARM1 (CARM1)
→
p53 (tetramer) complex (TP53)
(modification, collaborate)
An et al., Cell 2004
Evidence: mutant phenotype, physical interaction
Protein-Protein interactions - manually collected from original source literature:
Studies that report less than 10 interactions are marked with *
Text-mined interactions from Literome
Kim et al., BMC cancer 2010
(Breast Neoplasms...) :
Indeed,
CARM1 significantly
regulated both
p53 and NF-kappaB target gene transcription
Fuchs-Young et al., Breast Cancer Res Treat 2011
(Cell Transformation, Neoplastic...) :
Previous studies from our laboratory have shown that
p53 regulates ER expression transcriptionally, by binding the ER promoter and forming a complex with
CARM1 , CBP, c-Jun, RNA polymerase II and Sp1